Cargando…
Hormonal therapy in uterine sarcomas
Uterine sarcomas (USs) are a group of rare but aggressive uterine malignancies, accounting for only 1% of the malignant tumors of female reproductive organs. Due to the high rate of recurrence and metastasis, the prognosis of USs is poor. Given the high mortality rate and limited clinical benefit of...
Autores principales: | Zang, Yuqin, Dong, Mengting, Zhang, Kai, Gao, Chao, Guo, Fei, Wang, Yingmei, Xue, Fengxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488133/ https://www.ncbi.nlm.nih.gov/pubmed/30897294 http://dx.doi.org/10.1002/cam4.2044 |
Ejemplares similares
-
The bidirectional association among female hormone‐related cancers: breast, ovary, and uterine corpus
por: Chen, Min‐Chi, et al.
Publicado: (2018) -
New Insights into Hormonal Therapies in Uterine Sarcomas
por: Maccaroni, Elena, et al.
Publicado: (2022) -
Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis
por: Zhang, Kai, et al.
Publicado: (2019) -
Intensity‐Modulated Proton and Carbon‐Ion Radiation Therapy in the Management of Head and Neck Sarcomas
por: Yang, Jing, et al.
Publicado: (2019) -
The roles and clinical applications of interleukins in endometrial carcinoma
por: Zang, Yuqin, et al.
Publicado: (2022)